NeuroTherapeutics raises $43 million

NeuroTherapeutics Pharma Inc. (Chicago, Ill.) raised $43 million in a series B round co-led by new investors Fidelity Biosciences; MPM Capital; and SR One. Pfizer Inc. (NYSE:PFE), also a new investor,...